AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients.
The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages.
It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products.
In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance.
Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys.
Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations.
It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs.
The company was found in 2006 and is headquartered in Rochester, Michigan.
Country | United States |
IPO Date | Nov 28, 2007 |
Industry | Medical - Healthcare Information Services |
Sector | Healthcare |
Employees | 135 |
CEO | Stephen L. Silvestro |
Contact Details
Address: 400 Water Street Rochester, Michigan United States | |
Website | https://www.optimizerx.com |
Stock Details
Ticker Symbol | OPRX |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001448431 |
CUSIP Number | 68401U204 |
ISIN Number | US68401U2042 |
Employer ID | 26-1265381 |
SIC Code | 7389 |
Key Executives
Name | Position |
---|---|
Stephen L. Silvestro | President & Interim Chief Executive Officer |
Edward Stelmakh C.M.A., M.B.A. | Chief Financial Officer & Chief Operating Officer |
Andrew Jacob D'Silva | Senior Vice President of Corporate Finance |
Brian Clark McCarthy | Chief Revenue Officer |
Dr. Doug Besch | Chief Product Officer |
Maira Alejandra | Media Relations Manager |
Marion K Odence-Ford | General Counsel & Chief Compliance Officer |
Sheryl Kearney | Human Resources Manager |
Terence J. Hamilton | Senior Vice President of Pharma |
Theresa Greco | Chief Commercial Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jan 10, 2025 | 8-K | Current Report |
Jan 08, 2025 | SCHEDULE 13G/A | [Amend] Filing |
Dec 27, 2024 | 4 | Filing |
Dec 27, 2024 | 4/A | [Amend] Filing |
Dec 27, 2024 | 4 | Filing |
Dec 27, 2024 | 4 | Filing |
Dec 27, 2024 | 4 | Filing |
Dec 27, 2024 | 4 | Filing |
Dec 23, 2024 | 8-K | Current Report |
Dec 20, 2024 | 4 | Filing |